Devroey P, Van Steirteghem A
Centre for Reproductive Medicine, Dutch-speaking Brussels Free University (Vrije Universiteit Brussel), Laarbeeklaan 101, B-1090 Brussels, Belgium.
Hum Reprod Update. 2004 Jan-Feb;10(1):19-28. doi: 10.1093/humupd/dmh004.
This review summarizes the introduction of ICSI in the early 1990s as an assisted fertilization procedure in couples with severe male factor infertility, who could not be helped by conventional IVF. As for current practice, the indications for ICSI using fresh or frozen-thawed ejaculated, epididymal or testicular sperm are reviewed as well as some reports on the use of ICSI in non-male infertility. The main steps in an ICSI cycle are well standardized by now; it is rare that ICSI cannot be carried out and the results in terms of fertilization, embryo transfer and clinical pregnancy rate have been consistent for many years, indicating that a substantial number of couples can now have their own genetic child instead of having to use artificial insemination with donor sperm. This review also emphasizes the importance of assessing the risk of ICSI for the children: there is a slight increase in de novo chromosomal abnormalities, the major congenital malformation rate is similar for IVF and ICSI (between 3 and 4%), and at approximately 2 years of age the developmental outcome as assessed by the Bayley scale is similar for IVF and ICSI. Recent publications mention that a few children are affected by diseases caused by imprinting disorders. Future studies are needed to assess the association between assisted reproductive technologies and imprinting disorders. ICSI is frequently used in couples undergoing preimplantation genetic diagnosis. PGD stricto sensu as well as PGD for aneuploidy screening and for Klinefelter patients are reviewed using the ESHRE PGD Consortium data.
本综述总结了20世纪90年代初将卵胞浆内单精子注射(ICSI)作为一种辅助受精程序引入的情况,该程序用于患有严重男性因素不孕症且无法通过传统体外受精(IVF)得到帮助的夫妇。至于目前的实践,对使用新鲜或冻融的射出精子、附睾精子或睾丸精子进行ICSI的适应症以及一些关于ICSI在非男性不孕症中应用的报告进行了综述。目前,ICSI周期的主要步骤已经得到很好的标准化;现在很少有无法进行ICSI的情况,并且受精、胚胎移植和临床妊娠率多年来一直保持稳定,这表明现在相当数量的夫妇能够拥有自己的亲生孩子,而不必使用供体精子进行人工授精。本综述还强调了评估ICSI对儿童风险的重要性:新发染色体异常略有增加,IVF和ICSI的主要先天性畸形率相似(在3%至4%之间),并且在大约2岁时,通过贝利量表评估的发育结果在IVF和ICSI中相似。最近的出版物提到,一些儿童受到由印记障碍引起的疾病的影响。需要进一步的研究来评估辅助生殖技术与印记障碍之间的关联。ICSI经常用于接受植入前基因诊断的夫妇。使用欧洲人类生殖与胚胎学会(ESHRE)植入前基因诊断联盟的数据,对狭义的植入前基因诊断以及用于非整倍体筛查和克兰费尔特综合征患者的植入前基因诊断进行了综述。